Compare the Effect of a Remote Monitoring System Using the EXACT Tool to Reduce Hospitalizations Due to Chronic Obstructive Pulmonary Disease (COPD) Exacerbations. EXACT = Exacerbations of Chronic Pulmonary Disease Tool.

PHASE1CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Remote Patient Monitoring in COPD Patients
Interventions
DEVICE

Remote Patient Monitoring

Remote patient monitoring system including exacerbations of chronic pulmonary disease Tool - Patient Reported Outcome (EXACT PRO), Lung Monitor, and Pulse Oximeter

OTHER

Usual care

Patients in the usual care arm will continue their normally established procedures of nurse/physician contact and evaluation, as is considered standard for each individual practitioner in the study.

Trial Locations (20)

17007

Novartis Investigative Site, Girona

25198

Novartis Investigative Site, Lleida

28034

Novartis Investigative Site, Madrid

28040

Novartis Investigative Site, Madrid

28220

Novartis Investigative Site, Majadanonda

29620

Novartis Investigative Site, Torremolinos

08025

Novartis Investigative Site, Barcelona

08035

Novartis Investigative Site, Barcelona

08036

Novartis Investigative Site, Barcelona

08907

Novartis Investigative Site, L'Hospitalet de Llobregat

08830

Novartis Investigative Site, Sant Boi de Llobregat

08190

Novartis Investigative Site, Sant Cugat del Vallès

08970

Novartis Investigative Site, Sant Joan Despí

785 21

Novartis Investigative Site, Gagnef

Unknown

Novartis Investigative Site, Gothenburg

456 31

Novartis Investigative Site, Kungshamn

222 22

Novartis Investigative Site, Lund

SE-221 85

Novartis Investigative Site, Lund

831 83

Novartis Investigative Site, Östersund

113 61

Novartis Investigative Site, Stockholm

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY